Malaysia Healthcare strengthens Medan outreach as demand for second opinions grows

International

Indonesian patients continue to rely on Malaysia for accessible, high-quality treatment abroad

Malaysia is reinforcing its position as a trusted healthcare destination for Indonesian patients. Returning to Medan after its last major outreach in 2022, Malaysia Healthcare is reconnecting with a market that increasingly seeks timely treatment and reliable second medical opinions abroad. The initiative reflects sustained demand for internationally accredited care, specialised expertise and patient-focused services at competitive costs.

Strong corridor between Medan and Penang

Over the years, a well-established healthcare corridor has developed between Medan and Penang. The region covers a population of more than 15 million people, with Medan serving as a key gateway for patients from across North Sumatra, including Aceh, Padang, Pekanbaru and Binjai.

Geographical proximity plays a decisive role. At a distance of around 160 kilometres across the Straits of Malacca, Penang can be reached in approximately 40 to 45 minutes by air. Around 56 weekly flights connect Medan with Malaysia’s major hospital hubs, making access to treatment both fast and convenient.

Indonesian patients are a central pillar of Malaysia’s medical tourism sector, accounting for roughly 65 per cent of total revenue. This sustained demand has significantly shaped the country’s healthcare travel ecosystem.

Strategic focus on regional collaboration

The Malaysia Healthcare Travel Council continues to strengthen its engagement in Medan under the national Malaysia Healthcare brand. Guided by the “Healing Meets Hospitality” positioning and aligned with the Malaysia Year of Medical Tourism 2026, the initiative aims to deepen regional cooperation and improve access to trusted treatment options across Southeast Asia.

Leading hospitals engage directly with patients

As part of the programme, Malaysia Healthcare is bringing a broad delegation of leading hospitals to the city through MHX Medan 2026. Participating institutions include Island Hospital Penang, Institut Jantung Negara, Mahkota Medical Centre and Subang Jaya Medical Centre, alongside a wide range of specialised providers covering cardiology, oncology, orthopaedics, fertility treatment and comprehensive health screening.

Visitors will have the opportunity to consult specialists directly, explore treatment pathways and obtain second opinions on complex diagnoses. The format is designed to provide clarity for patients considering treatment abroad while strengthening ties between healthcare providers and regional partners.

Ambitious targets for 2026

MHX Medan 2026 builds on the results of the 2022 edition, which generated 1,514 patient enquiries. The organisers now aim to exceed this benchmark with a target of at least 1,665 healthcare leads from the Medan market.

The event is expected to attract not only patients and families seeking medical guidance, but also facilitators and industry stakeholders interested in expanding Malaysia–Indonesia healthcare collaboration.